Custom service

Targeting Peptide Modification and Conjugation

Modify targeting peptides for stability and conjugate them to payloads

Turnaround: 4–6 weeksTypical scale: 1 – 100 mg targeting peptideChemistry options: cyclization and D-residue stabilization; PEG-spacer payload attachment; chelator and dye installation

The service is built around cyclization and D-residue stabilization. Depending on the molecule we may move to PEG-spacer payload attachment or chelator and dye installation to improve stability, loading or yield, and every batch is released with modified or conjugated targeting peptide with loading QC.

Because Targeting Peptide Modification and Conjugation projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Attaching targeting motifs to drugs, beads or nanoparticles

Stabilizing motifs against serum proteases

Conjugations where the payload destroys receptor binding

Targets whose soluble ectodomain cannot be produced or sourced for binding assays

Binding affinity and specificity data are generated in-house for every campaign: IC50 or Kd against the intended target, plus counterscreens against the closest homologs. Release also includes purity, identity and, for conjugated variants, loading ratio.

Service Highlights

  • Cyclization and D-residue stabilization as the default route, with PEG-spacer payload attachment held as a proven fallback
  • Chelator and dye installation worked into the design where the application requires it
  • Receptor-binding assays run against the intended target before any scale-up
  • Analytical confirmation of every intermediate before the final release
  • Specificity is measured against a negative-cell or negative-receptor panel, not asserted
  • Modified or conjugated targeting peptide with loading QC delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Target analysis

    We map the binding site, receptor biology and homolog panel that the Targeting Peptide Modification and Conjugation campaign must respect.

  2. Motif selection or discovery

    A motif is selected from literature, or discovered by screening, and candidate sequences are ranked.

  3. Synthesis & modification

    Candidates are synthesized with cyclization and D-residue stabilization applied to stabilize or direct the motif.

  4. Binding & specificity testing

    Affinity is measured on the target and counterscreens run on homologs and irrelevant cells.

  5. Optimization round

    Sequences are iterated — alanine scanning, truncation, D-substitution — until the specification is met.

  6. Scale-up & release

    The final variant is produced in quantity and Modified or conjugated targeting peptide with loading QC is released with the full data package.

Specifications & timeline

Turnaround
4–6 weeks
Typical scale
1 – 100 mg targeting peptide
Chemistry options
cyclization and D-residue stabilization; PEG-spacer payload attachment; chelator and dye installation
Deliverable
Modified or conjugated targeting peptide with loading QC
QC package
HPLC purity, MS identity, binding assay report
Shipping
Ambient or blue ice as stability requires

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.